Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maine for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maine only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maine (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Julia Moukharskaya (NPI 1730341702)

Field	Value
Entity Type	Individual
Organization	Julia Moukharskaya
Address	105 Topsham Fair Mall Rd Unit 1
City	Topsham
State	ME
ZIP	04086
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	June 30, 2008

Payer Source	Total Paid
Medicare	$519.1K
Medicaid	$0

Key Findings

This provider’s Medicare activity is narrowly concentrated in oncology drug administration: three J-codes (J9271, J0897, J1439) plus chemotherapy administration codes account for the bulk of clinical services and revenue, with the precomputed top-3 Medicare codes representing 78.0% of total Medicare revenue. The prominence of J9271 (pembrolizumab) and J0897 (denosumab) combined with multiple chemotherapy administration CPTs (96413, 96401, 96402, 96417) indicates the practice functions primarily as a cancer treatment/infusion provider rather than a general primary care clinic.

J9271 is the single largest revenue driver, accounting for $283.8K or 55.5% of the provider’s total Medicare revenue, reflecting heavy use of pembrolizumab infusions in this panel. Nationally this provider ranks #1566 of 1841 for J9271 (14th percentile), which the source labels as a typical, unremarkable volume for the code — suggesting they are administering high-cost immunotherapy frequently for their own relatively small Medicare panel but are not a national high-volume center for this drug.

J0897 (denosumab) contributes $73.4K (14.4% of Medicare revenue) and ranks #3449 of 10057 nationally (65th percentile), a modestly above-average position among clinicians who bill this code. The combination of J9271 and J0897 indicates concurrent management of oncology and supportive bone-targeted therapy in this practice, consistent with specialist hematology/oncology care patterns.

Office E/M codes 99214 and 99215 together represent a minority share of revenue ($41.7K and $13.8K respectively) and rank in the higher national percentiles for volume (99214 at the 89th percentile, 99215 at the 81st percentile). This suggests the provider delivers a meaningful volume of evaluation-and-management visits in addition to infusion services, supporting longitudinal oncology care for established Medicare patients rather than episodic consults only.

There is effectively single-payer exposure: the profile shows Total Medicare revenue of $519.1K and no Medicaid billing on file, so this provider operates with negligible Medicaid participation. This concentration means revenue is highly dependent on Medicare-covered oncology drug and infusion billing rather than a mixed public-payer base.

Competitive standing across key services is mixed: for high-revenue J9271 the provider is a modest national participant (14th percentile), while for J0897 they sit above the median (65th percentile). Several supportive lab and infusion codes (e.g., 80053, 85025, 36415) rank in high national percentiles (near or above the 80th–89th percentiles), indicating routine use of common monitoring and venipuncture services consistent with an active infusion practice.

Tenure on file is long: the NPI was enumerated on 2008-06-30 (~18 years ago), indicating established practice presence and likely continuity of care for Medicare beneficiaries over an extended period. This longevity aligns with sustained Medicare revenue concentrated in oncology infusion services.

Other coded services are supportive and low-revenue by comparison — examples include J1439 (ferric carboxymaltose) at $22.5K (4.4% of Medicare revenue) and several chemotherapy administration add-on and IV infusion codes (96365, 96375, 96417) each contributing under 1%–1% of revenue. These entries reinforce a workflow centered on drug infusions with routine ancillary lab work and injection procedures rather than large volumes of diagnostic testing or surgical procedures.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

43 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	6,600	$40	$283.8K
J0897	Injection, denosumab, 1 mg	4,080	$20	$73.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	470	$90	$41.7K
J1439	Injection, ferric carboxymaltose, 1 mg	22,500	$1	$22.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	240	$90	$22K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	110	$130	$13.8K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	30	$330	$8.9K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	600	$10	$6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	90	$60	$5.7K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	600	$10	$4.2K

Showing 1–10 of 43

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 43 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maine Distribution

Julia Moukharskaya — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maine

Full comparison — all codes billed, vs. state median

43 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	10	16,450	$40	$699.2K
J0897	7	20	2,730	$20	$86.4K
J1439	7	10	24,750	$1	$32.2K
96413	10	30	170	$100	$20.6K
J1454	8	10	60	$340	$18.3K
99214	38	2,500	70	$70	$7.2K
96401	6	10	80	$50	$6.1K
96365	16	30	90	$50	$5.6K
99215	73	780	30	$100	$4.8K
90662	178	230	30	$70	$4.6K

Showing 1–10 of 43

Related Providers

Other providers that share a Tax Identification Number (TIN) with Julia Moukharskaya, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Central Maine Medical Center	ME	General Acute Care Hospital	$0	$76.1M
Central Washington Health Services Association	WA	General Acute Care Hospital	$0	$63.5M
Wenatchee Valley Hospital	WA	General Acute Care Hospital	$0	$22.9M
Wenatchee Valley Hospital	WA	Multi-Specialty Clinic/Center	$0	$19.5M
Wenatchee Valley Hospital	WA	Rural Health Clinic/Center	$0	$14.1M
Central Washington Health Services Association	WA	General Acute Care Hospital	$0	$10.9M
Wenatchee Valley Hospital	WA	Rural Health Clinic/Center	$0	$8.6M
Wenatchee Valley Hospital	WA	Rural Health Clinic/Center	$0	$7.4M
Central Washington Health Services Association	WA	Emergency Medical Services (Emergency Medicine) Physician	$0	$7M
Wenatchee Valley Hospital	WA	Rural Health Clinic/Center	$0	$5.6M

Nearby Providers

Other providers in the same ZIP code as Julia Moukharskaya, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Benton	ME	Hematology & Oncology Physician	$2.6M	$0
Brian Haney	ME	Hematology & Oncology Physician	$1.2M	$0
Chonko Occupational Therapy, LLC	ME	Occupational Therapist	$0	$772.2K
Greater Brunswick Physical Therapy P.A.	ME	Physical Therapist	$0	$511.7K
Town Of Topsham	ME	Land Ambulance	$126.7K	$205.4K
Jose Ventura	ME	Family Medicine Physician	$50.9K	$197.8K
Michael Davis	ME	Family Nurse Practitioner	$109.4K	$0
Cvs State Capital LLC	ME	Pharmacy	$70.5K	$0
David Inger	ME	Family Medicine Physician	$36.6K	$0
Megan Hutcherson	ME	Pediatric Occupational Therapist	$33.7K	$0

Julia Moukharskaya — Billing Profile & Reimbursement Data

Sign up for Julia Moukharskaya — Billing Profile & Reimbursement Data policy alerts

Julia Moukharskaya — Billing Profile & Reimbursement Data

Sign up for Julia Moukharskaya — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References